1.34
price down icon1.47%   -0.02
after-market After Hours: 1.35 0.01 +0.75%
loading

Clearmind Medicine Inc (CMND) Stock Split History

Clearmind Medicine Inc has split its stock 2 times since its initial public offering (IPO). The first stock split occurred on September 30, 2022 with the ratio of 1-for-30, meaning that for 30 shares of CMND owned pre-split, shareholders then owned 1 share. The most recent stock split took place on November 28, 2023 on a 1-for-30 basis.

These actions have increased CMND stock's liquidity and made it more appealing to a larger group of investors. However, it's important to remember that a stock split only change the number of shares and the price per share with no impact on Clearmind Medicine Inc's total market capitalization.

For more detailed information of Clearmind Medicine Inc's stock splits, view the table below:

CMND stock split list

Date Split Ratio
2023-11-28 1 - for - 30
2022-09-30 1 - for - 30

Will Clearmind Medicine Inc Stock Split in 2024?

The answer will depend on the decisions of the company's managers and market volatility. Clearmind Medicine Inc has not made an official announcement regarding whether it will enact a stock split or reverse stock split, but it has a history of doing so when CMND stock prices become too high or too low for retail investors. Therefore, the ultimate decisions will certainly be made by Clearmind Medicine Inc's board of directors. Typically, no action is taken until its price per share reaches a specific threshold.

Stock Splits of Industry Leaders

Ticker Symbol Latest Split Date Split Ratio
VRTX 2000-08-24 2 - for - 1
UTHR 2009-09-23 2 - for - 1
MRNA 2017-08-03 1 - for - 10
INCY 2000-09-01 2 - for - 1
GMAB 2018-05-01 5 - for - 1
INSM 2011-03-03 1 - for - 10
RPRX 2010-10-15 1 - for - 4
TECH 2022-11-30 4 - for - 1
SRPT 2012-07-12 1 - for - 6
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Cap:     |  Volume (24h):